Mark Massaro Analyst PerformanceManaging Director, Senior Equity Research Analyst at BTIG ResearchMark Massaro is a stock analyst at BTIG Research, covering 35 publicly traded companies across a range of sectors. Over the past year, Mark Massaro has issued 10 stock ratings, including buy, hold, and sell recommendations. While full access to Mark Massaro's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Mark Massaro's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Ratings, Coverage, and Performance StatisticsAnalyst RatingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings295 Last 10 YearsBuy Recommendations76.82% 222 Buy RatingsCompanies Covered35 Unique Companies Ratings Distribution289RatingsDistribution of strong buy, buy, hold, and sell ratings by Mark Massaro.RatingPercentageCount Strong Buy0.0%0 ratings Buy76.8%222 ratings Hold22.8%66 ratings Sell0.3%1 ratingsOut of 289 total stock ratings issued by Mark Massaro at BTIG Research, the majority (76.8%) have been Buy recommendations, followed by 22.8% Hold and 0.3% Sell.Best & Worst CallsBest Call0000.0%TTOOFeb 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%BLINov 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ82.9% of companies on NASDAQ29 companiesNYSE14.3% of companies on NYSE5 companiesOTCMKTS2.9% of companies on OTCMKTS1 companyMark Massaro, an analyst at BTIG Research, currently covers 35 companies listed on NASDAQ, NYSE and OTCMKTS, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical33 companies94.3%Computer and Technology1 company2.9%Miscellaneous1 company2.9%Mark Massaro of BTIG Research specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology and companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE6 companies17.1%MEDICAL SERVICES5 companies14.3%MED INSTRUMENTS4 companies11.4%MED PRODUCTS3 companies8.6%MEDICAL INFO SYS2 companies5.7%MEDICAL LABORATORIES2 companies5.7%ANALYTICAL INSTRUMENTS2 companies5.7%SURGICAL & MEDICAL INSTRUMENTS2 companies5.7%DIAGNOSTIC SUBSTANCES2 companies5.7%MED - GENERIC DRG1 company2.9%PHARMACEUTICAL PREPARATIONS1 company2.9%MED - OUTP/HM CRE1 company2.9%SKILLED NURSING CARE FACILITIES1 company2.9%MEASURING & CONTROLLING DEVICES1 company2.9%Miscellaneous1 company2.9%MED/DENTAL - SUPP1 company2.9% About Mark MassaroMark Massaro is a Managing Director and BTIG Life Science and Diagnostic Tools Analyst. Prior to BTIG, he served as the Chief Financial Officer at ArcherDX, Inc., an oncology diagnostics and pharmaceutical services company, which was acquired by Invitae Corporation. Previously, Mr. Massaro was a Managing Director and Senior Equity Research Analyst within Diagnostics and Life Science Tools at Canaccord Genuity, where he spent more than eight years focused on high-growth, precision medicine and next-generation sequencing companies, as well as molecular and point-of-care diagnostics, reference labs and animal health. He was named a “Rising Star” in Institutional Investor’s All America Survey for life science and diagnostics tools in October 2016. Earlier in his career, Mr. Massaro was an Associate Equity Analyst within Healthcare Services at Avondale Partners and held corporate finance and financial reporting roles at Dell EMC and Fidelity Investments. He earned an MBA from Babson College and a BA in economics and Spanish from the University of Massachusetts – Amherst.Follow on LinkedIn Mark Massaro's Ratings History at BTIG Research Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Time Frame Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsLUCDLucid Diagnostics9/5/2025Boost Price Target$1.38$2.50Buy$0.0000.00% ROIGHGuardant Health9/4/2025Boost Price Target$59.08$70.00Buy$0.0000.00% ROIDNAGinkgo Bioworks8/25/2025Boost Price Target$12.51$9.00Sell$0.0000.00% ROITEMTempus AI8/20/2025Boost Price Target$73.08$85.00Buy$0.0000.00% ROIEXASExact Sciences8/12/2025Lower Price Target$41.52$60.00Buy$0.0000.00% ROIMXCTMaxCyte8/11/2025Reiterated Rating$1.38Neutral$0.0000.00% ROITEMTempus AI8/8/2025Initiated Coverage$58.74$60.00Buy$0.0000.00% ROIPSNLPersonalis8/6/2025Set Price Target$4.52$6.00$0.0000.00% ROITEMTempus AI4/21/2025Initiated Coverage$40.42$60.00Buy$0.0000.00% ROIMXCTMaxCyte3/12/2025Set Price Target$3.47$6.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.